A retrospective study of 57,448 female patients with uncomplicated urinary tract infections compared antibiotic courses lasting at least 8 days with courses lasting 5 to 7 days.
2
Extended treatment was associated with a 20% higher overall rate of treatment-related adverse events than 5- to 7-day treatment (rate ratio, 1.20; 95% CI, 1.09-1.32).
3
Extended treatment was associated with higher rates of gastrointestinal, genitourinary, endocrine, and hypersensitivity events.
4
The study used US electronic health records from May 2023 through March 2025 and assessed adverse events for up to 90 days after treatment-duration classification.
5
The study was funded by GSK; several authors were GSK employees, and Analysis Group received GSK funding to conduct the study.